JNJ-39220675

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-39220675, covering 2013-08-30 to 2013-08-30. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy Study of JNJ-39220675 and Pseudoephedrine in Participants With Allergic Rhinitis [Phase 2]